Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease

Georg Semmler, Teresa Binter, Karin Kozbial, Philipp Schwabl, Stefanie Hametner‐Schreil, Alberto Zanetto, Sabrina Gavasso, David Chromy, David J.M. Bauer, Benedikt Simbrunner, Bernhard Scheiner, Theresa Bucsics, Albert F. Stättermayer, Matthias Pinter, Petra Steindl‐Munda, Rainer Schöfl, Francesco Paolo Russo, Paolo Simioni, Michael Trauner, Peter Ferenci, Thomas Reiberger, Mattias Mandorfer – 13 July 2020

Opioid Avoidance in Liver Transplant Recipients: Reduction in Postoperative Opioid Use Through a Multidisciplinary Multimodal Approach

Heather L. Kutzler, Richard Gannon, William Nolan, Leah Meisterling, Marbelia Cech, Danielle Gleason, Justin Uzl, Caroline Rochon, Bejon Maneckshana, Oscar K. Serrano, Jenifer Riley, David O’Sullivan, Eva Urtasun Sotil, Michael Einstein, Patricia Sheiner – 13 July 2020 – The prevalence of substance use disorder in the liver transplantation (LT) population makes postoperative pain management challenging. We report our initial experience with a novel, comprehensive, multidisciplinary opioid avoidance pathway in 13 LT recipients between January 2018 and September 2019.

Subscribe to